Klinische Studie Novartis H

Klinische Studie Novartis H5N1+MF59 in Polen an 350 Probande...
1 von 3
http://www.europnews.de/2009-08-28-klinische-studie-novartis-...
22.11.2009 23:24
Klinische Studie Novartis H5N1+MF59 in Polen an 350 Probande...
2 von 3
http://www.europnews.de/2009-08-28-klinische-studie-novartis-...
Klinische Studie Novartis
H5N1+MF59 in Polen an 350
Probanden – 21 gestorben!
28.08.2009 von Administrator
Leave a reply »
21 von 350 teilnehmenden Obdachlosen wärend der Studie gestorben, da sollte man genauer
hinsehen. Haben es unsere Medien genauer hingesehen und darüber berichtet? Wer hat über die
Studienfolgen in Polen berichtet? Weiß einer der Probanden in Deutschland bei der Aktuellen
Studie mit AS03 von diesen Vorfällen? Auch etwas zu den unten genannten Rattenversuchen?
Scheinbar sind von GlaxoSmithKline vor Menschenversuche lediglich der Kurzzeitversuche mit den
30 Frettchen publik. Diese von GSK bezahlte Studie untersucht lediglich wie starkt AS03 die
Wirkung der Antigens verstärkt.
Risikountersuchung? Fehlanzeige!
Der Immunverstärker MF59 von Novartis ist übrings auch interessant: (squalene 9.75 mg,
polysorbate 80 1.175 mg, sorbitan trioleate 1.175mg)
—Novartis, another big pharma, announced on 13 June that it, too, has produced a swine flu vaccine
using cell-based technology and the proprietary adjuvant MF59®. The MF59® adjuvant is oil based
and contains Tween80, Span85, and squalene [25]. In studies of oil-based adjuvants in rats, the
animals were rendered crippled and paralyzed. Squalene brought on severe arthritis symptoms in
rats, and studies in humans given from 10 to 20 ppb (parts per billion) of squalene showed severe
immune system impact and development of autoimmune disorders [26].
Novartis was in the news in 2008 for a clinical trial of a H5N1 vaccine in Poland. The trial was
administered by local nurses and doctors who gave the vaccine to 350 homeless people, leaving
21 died; and were prosecuted by the Polish police [27, 28]. Novartis claimed the deaths were
unrelated to the
H5N1 vaccine [29], which had been “tested on 3500 other people without any deaths.”
—http://www.pandemicfluonline.com/wp-content/uploads/2009/07/FasttrackedSwineFluVaccineUnderFire.pdf [http://www.pandemicfluonline.com/wp-content
/uploads/2009/07/Fast-trackedSwineFluVaccineUnderFire.pdf]
(Lesenswert!)
25. Kenney RT and Edelman R. Survey of human-use adjuvants. Expert Review of Vaccines April
2003;2(2):167-88.
26. “Vaccines may be linked to Gulf War Syndrome, Chiroweb.com, June 12, 2000.
www.chiroweb.com/archives/18/13/04.html [http://www.chiroweb.com/archives/18/13
/04.html]
27. “Homeless people die after bird flu vaccine trial in Poland”, Mathew Day, Telegraph, 2 July
2008.
http://www.telegraph.co.uk/news/worldnews/europe/poland/2235676/Homeless-peopledie-after-bird-flu-vaccine-trial-in-Poland.html [http://www.telegraph.co.uk/news/worldnews
/europe/poland/2235676/Homeless-people-die-after-bird-flu-vaccine-trial-in-Poland.html]
28. “Homeless people die after trials of bird-flu vaccine”, 10 July 2008, Pharmaceutical Portal for
Poland,
www.pharmapoland.com/next.php?id=62409 [http://www.pharmapoland.com
/next.php?id=62409]
29. “Polish industry not dented by deaths”, Emma Dorey, Entrepreneur, 21 July 2008.
http://www.entrepreneur.com/tradejournals/article/181991358.html
[http://www.entrepreneur.com/tradejournals/article/181991358.html]
Gewissenhafte Prüfung von neuen Wirkstoffen sähe in vielen Punkten anders aus! Diese
Immunverstärker sollten dieses Jahr nicht mehr zugelassen werden!
Gruss
Bookmarken bei:
[javascript:window.location='http%3A%2F
%2Fdigg.com%2Fsubmit%3Fphase%3D2%26amp%3Burl%3Dhttp%253A%252F%252Fwww.europnews.de%2
klinische-studie-novartis-h5n1-mf59-in-polen-an-350-probanden21-gestorben.html%26amp%3Btitle%3DKlinische%2520Studie%2520Novartis%2520H5N1%252BMF5
[javascript:window.location='http%3A%2F
%2Fdelicious.com%2Fpost%3Furl%3Dhttp%253A%252F%252Fwww.europnews.de%252F2009-08-28klinische-studie-novartis-h5n1-mf59-in-polen-an-350-probanden21-gestorben.html%26amp%3Btitle%3DKlinische%2520Studie%2520Novartis%2520H5N1%252BMF5
[javascript:window.location='http%3A%2F
22.11.2009 23:24
Klinische Studie Novartis H5N1+MF59 in Polen an 350 Probande...
3 von 3
© 2009 Europnews · Proudly powered by WordPress & Green Park 2 von Cordobo.
Valid XHTML 1.0 Transitional | Valid CSS 3
http://www.europnews.de/2009-08-28-klinische-studie-novartis-...
Back to Top
22.11.2009 23:24